News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Aakash Desai: LUPER – Lurbinectedin plus pembrolizumab in SCLC
Aakash Desai/LinkedIn
Feb 12, 2025, 08:59

Aakash Desai: LUPER – Lurbinectedin plus pembrolizumab in SCLC

Aakash Desai, Assistant Professor at UAB O’Neal Comprehensive Cancer Center, shared an article Antonio Calles and colleagues authored post on X:

“In JTO online, LUPER: lurbinectedin + pembrolizumab in SCLC 

• RR: 46.4% (3 CR)
• DOR: 7.8m | PFS: 4.6m | OS: 10.5m

My Takeaway? Limited impact—IO is standard in 1L, and emerging 2L options post-IO show strong efficacy as well.”

Lurbinectedin plus pembrolizumab in relapsed small cell lung cancer (SCLC): the phase I/II LUPER study

Authors: Antonio Calles et al.

Aakash Desai: LUPER - Lurbinectedin plus pembrolizumab in SCLC

Aakash Desai Alejandro Navarro Antonio Calles Bernard Gaston Doger Speville Uribe cancer Daniel Alcalá-López Elena Corral de la Fuente Emiliano Calvo Enric Álvarez Colomé Enriqueta Felip Ernest Nadal Jorge Ramon-Patino Jose Rodríguez-Morató Maria de Miguel Maria Jove Marta Arregui Melissa Fernández-Pinto Olga Boix OncoDaily Oncology Pedro Rocha Ramón Palmero Rosa Álvarez Victor Moreno
Special Coverage
OncoDaily Pulse
Feb 12, 2025, 11:30
ACT for Children: Tackling Inequities in Childhood Cancer Through Unique Global Collaboration
Feb 12, 2025, 11:25
Breast Cancer: Symptoms Causes, Stages, Diagnosis and Treatment
Oncolibrary
Feb 12, 2025, 10:41
New Paper Alert: Survival and Treatment Outcomes of Pancreatic Cancer in Armenia: A 12-Year Retrospective Study
Blog
Feb 12, 2025, 10:04
International Cancer Foundation's first Regional Partners Forum
Blog
Feb 12, 2025, 10:03
POHER Scholar alum Martha Kamanga at the Levy Mwanawasa University Teaching Hospital
Insight
Feb 12, 2025, 09:49
Nathan Cherny on the ongoing disparities in access to essential cancer medicines - ESMO
Science
Feb 12, 2025, 09:47
Suman Kumar Vodnala: A novel three-gene "MANAscore" algorithm for lung cancer and melanoma patients
Blog
Feb 12, 2025, 09:40
Yvonne Diaz at the Pistoia Alliance's annual London Conference - Oncogene Cancer Research
Blog
Feb 12, 2025, 09:37
Gertjan Rasschaert: Immunosensitivity cuts across mismatch repair status in colorectal cancer
Science
Feb 12, 2025, 09:32
Evolving field of immunotherapy: pioneering new paths in SCLC by Antonious Ziad Hazim et al.
Insight
Feb 12, 2025, 09:31
Results from phase 3 CEPHEUS study are out - MSK Department of Medicine
Science
Feb 12, 2025, 09:24
High-purity CTC RNA sequencing identifies prognostic prostate cancer phenotypes by Marina Sharifi et al.